Organogenesis Holdings
ORGO
113 hedge funds and large institutions have $172M invested in Organogenesis Holdings in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 45 reducing their positions, and 33 closing their positions.
51% more capital invested
Capital invested by funds: $114M → $172M (+$58M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.21% less ownership
Funds ownership: 40.66% → 39.45% (-1.2%)
14% less funds holding
Funds holding: 131 → 113 (-18)
24% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 45
55% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 33
80% less call options, than puts
Call options by funds: $92K | Put options by funds: $458K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.54M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$3.67M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.87M |
| 4 |
Millennium Management
New York
|
+$1.76M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.94M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.59M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.04M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.85M |
| 5 |
Renaissance Technologies
New York
|
-$1.6M |
ORGO Hedge Fund Activity: Q2 2023 in Review
113 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q2 2023, worth a combined $172M — up 51% from $114M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of ORGO and 15 opened new positions — a net loss of 18 holders — while 45 trimmed existing stakes and 34 added.
The largest buyer was Soleus Capital Management, adding an estimated $5.54M. The largest seller was Federated Hermes, cutting an estimated $4.94M.
- 113 institutional investors held Organogenesis Holdings (ORGO) as of Q2 2023, down from 131 in Q1 2023.
- Funds reported $172M of Organogenesis Holdings stock for Q2 2023, up 51% quarter-over-quarter.
- 15 funds opened new Organogenesis Holdings positions in Q2 2023 and 33 closed out, a net change of -18 holders.
- The largest Organogenesis Holdings buyer in Q2 2023 was Soleus Capital Management, an estimated $5.54M added.
- The largest Organogenesis Holdings seller in Q2 2023 was Federated Hermes, an estimated $4.94M sold.
Based on aggregated 13F filings for Q2 2023.